v3.26.1
Shareholders' Equity - (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 56 Months Ended
May 13, 2026
Jul. 11, 2025
Mar. 18, 2025
Jul. 29, 2020
Jun. 30, 2026
Jun. 30, 2026
Mar. 18, 2025
Dec. 31, 2025
Authorized share capital                
Proceeds from issuance or sale of equity   $ 48,600            
Issuance of common shares, net of issuance costs           $ 10,890    
Issuance of common shares, net of issuance costs (in shares)   31,500,000            
Proceeds from issuance of common shares, net of issuance costs           $ 10,890    
Stock issuance cost   $ 3,900            
Warrants outstanding         16,412,925 16,412,925   16,412,925
ATM Program                
Authorized share capital                
Issuance of common shares, net of issuance costs             $ 2,800  
Issuance of common shares, net of issuance costs (in shares)           5,526,590    
Proceeds from issuance of common shares, net of issuance costs           $ 10,900    
Stock issuance cost           $ 300    
ATM Program | Maximum                
Authorized share capital                
Proceeds from issuance or sale of equity       $ 50,000        
Issuance of common shares, net of issuance costs     $ 77,800          
Controlled Equity Offering Sales Agreement                
Authorized share capital                
Issuance of common shares, net of issuance costs (in shares)           0    
Sales commission percentage 3.00%              
Series A common warrants                
Authorized share capital                
Exercise of Series A common stock warrants, net of issuance costs (in shares)         6,678,642 12,345,308    
Proceeds from exercise of warrants, net of issuance costs         $ 9,400 $ 17,400    
Underwriting commissions         $ 600 $ 1,100    
Warrants outstanding         15,705,662 15,705,662    
Series B common warrants                
Authorized share capital                
Warrants outstanding         34,335,669 34,335,669